Cook Medical Showcases Latest Advancements for Treating Vascular Disease at ISET 2010


Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy. In addition to live and simulated device demonstrations in booth #208, Cook's activities at the meeting include data presentations from two ongoing clinical trials and breakout sessions on common and debilitating conditions such as varicocele.

Rob Lyles, vice president and global leader of Cook's peripheral intervention business unit said, The number of people affected by some form of peripheral vascular disease is increasing at alarming rates worldwide,” said Rob Lyles, vice president and global leader of Cook's peripheral intervention business unit. Awareness is a fundamental line of attack for us against these spiking numbers. It is our mission to inform patients and physicians alike about the intricacies surrounding treatments that span the entire vascular disease spectrum and arm them with the technologies needed to improve outcomes.

Findings from the REFORM clinical trial evaluating the Formula™ Balloon Expandable Stent for the long-term treatment of renal artery stenosis following suboptimal angioplasty are being presented by Dr. Robert Bersin, medical director of endovascular services at Seattle Cardiology and Swedish Medical Center. Early data from the single-arm, 100-patient study suggest high technical and procedural success rates, clinically significant reductions in systolic blood pressure at one month, stable renal function, and no evidence of safety concern. Clinical follow-up will continue through three years, and enrollment for the European arm of a trial evaluating a drug-eluting version of the Formula stent for renal indications is scheduled to be announced at the LINC meeting in Germany later this month.